| Literature DB >> 34474501 |
Sheila M Everwijn1, Jiska F van Bohemen2, Nan van Geloven3, Fenna A Jansen1, Aalbertine K Teunissen1, Lieke Rozendaal4, Nico Blom4, Jan M van Lith1, Monique C Haak1.
Abstract
INTRODUCTION: Neurodevelopmental delay is more common in children born with congenital heart defects (CHD), even with optimal perinatal and peri-operative care. It is hypothesized that fetuses with CHD are prone to neurological impairment in utero due to their cardiac defect, possibly leading to delayed cortical development.Entities:
Mesh:
Year: 2021 PMID: 34474501 PMCID: PMC9293037 DOI: 10.1002/pd.6038
Source DB: PubMed Journal: Prenat Diagn ISSN: 0197-3851 Impact factor: 3.242
FIGURE 1Sylvian fissure staging. Sylvian fissure progressing from no visible echoscopic sign of sulcation to end‐stage sulcation
FIGURE 2Sulcal staging. Sulcus: parieto‐occipital, central, superior temporal, calcarine and cingulate progressing with gestational age from no visible echoscopic sign of sulcation to end‐stage sulcation
FIGURE 3Cortical area staging. Frontal, parietal, temporal, and occipital cortical areas progression with gestational age from no visible echoscopic sign of sulcation to end‐stage sulcation
Baseline characteristics for congenital heart defect cases and controls
| Characteristics | CHD cases | Controls |
|
|---|---|---|---|
| 97 subjects | 61 subjects | ||
| Maternal age in years—mean (SD) | 29 (4.2) | 32 (4.6) | 0.01 |
| BMI (kg/m2)—Mean (SD) | 23.7 (4.3) | 23.6 (3.9) | 0.97 |
| Maternal diabetes— | 3 (3) | 0 | 0.17 |
| Primigravidae— | 36 (37) | 20 (33) | 0.35 |
| Male gender— | 60 (62) | 28 (46) | 0.04 |
| No. of CHD cases | n.a. | ||
| Aortic arch hypoplasia and/or aortic stenosis— | 24 (25) | ||
| Tetralogy of Fallot or Fallot‐like defect— | 14 (14) | ||
| Transposition of the great arteries— | 14 (14) | ||
| Tricuspid or pulmonary atresia— | 6 (6) | ||
| HLHS— | 5 (5) | ||
| (Un)balanced atrioventricular septal defect— | 5 (5) | ||
| Ventricular septal defect— | 3 (3) | ||
| Other major CHD | 17 (18) | ||
| Other minor CHD | 9 (9) | ||
| Excluded cases— | |||
| Postnatal normal heart | 4 (4) | ||
| Non‐isolated cases | 8 (8) | ||
| Pregnancy outcome— | n.a. | ||
| Live birth | 81 (95) | 61 (100) | |
| Termination of pregnancy | 4 (5) | 0 (0) | |
| Mean GA at scanning—mean (SD) | |||
| 20 weeks | 20.9 (0.8) | 21.1 (0.8) | 0.49 |
| 24 weeks | 24.1 (0.8) | 24.2 (1.0) | 0.77 |
| 28 weeks | 28.3 (0.8) | 28.1 (0.8) | 0.36 |
| 32 weeks | 32.2 (0.8) | 32.1 (0.6) | 0.49 |
| 36 weeks | 36.2 (0.7) | 35.9 (0.5) | 0.04 |
Abbreviations: AVSD, atrioventricular septal defect; CHD, congenital heart disease; HLHS, hypoplastic left heart syndrome; TGA, transposition of the great arteries.
Other major CHD include truncus arteriosus, multiple level left obstruction syndrome (Shone's complex), double outlet right ventricle‐TGA, congenitally corrected TGA without additional cardiac anomalies, AVSD with pulmonary atresia, aortic‐left ventricular tunnel with severe distention of the left ventricle.
Other minor CHD include persistent left caval vein without obstruction of the left atrioventricular flow, restrictive foramen ovale, mild pulmonary stenosis.
*p ≤ 0.05, statistically significant.
FIGURE 4Progression of sulcal staging throughout pregnancy. (A) Sylvian fissure development. (B) Parieto‐occipital sulcus development. (C) Central sulcus development. (D) Cingulate sulcus development. (E). Calcarine sulcus development. Continuous line (‐‐‐), CHD‐fetuses; dotted line (…) control fetuses; x‐axis, sulcal grades; y‐axis, gestational age in weeks
FIGURE 5Progression of brain area staging throughout pregnancy. (A) Frontal area development. (B). Parietal area development. (C) Temporal area development. (D) Occipital area development. Continuous line (‐‐‐), CHD‐fetuses; dotted line (…) control fetuses; x‐axis, sulcal grades; y‐axis, gestational age in weeks
Results of mixed model analysis in fissure grading
| Average difference in grade over all times | Difference in maturation speed | ||||
|---|---|---|---|---|---|
| Difference | 95% CI |
|
| ||
| Sylvian | Unadjusted | −0.11 | −0.21; −0.01 | 0.03* | 0.90 |
| Adjusted | −0.12 | −0.23; −0.01 | 0.05* | 0.97 | |
| Parieto‐occipital | Unadjusted | −0.08 | −0.18; 0.02 | 0.11 | 0.01* |
| Adjusted | −0.05 | −0.16; 0.06 | 0.36 | 0.02* | |
| Central | Unadjusted | −0.08 | −0.19; −0.04 | 0.21 | 1.00 |
| Adjusted | −0.06 | −0.21; 0.09 | 0.44 | 0.98 | |
| Cingulate | Unadjusted | −0.22 | −0.34; −0.11 | <0.01* | 0.08 |
| Adjusted | −0.24 | −0.37; 0.10 | <0.01* | 0.19 | |
| Calcarine | Unadjusted | −0.13 | −0.24; 0.02 | 0.02* | 0.04* |
| Adjusted | −0.09 | −0.21; 0.03 | 0.15 | 0.07 | |
Note: Overall difference in grading represents the mean difference between scores in CHD and control cases. Speed of maturation represents the test on differences in progression with GA between scores of CHD and control cases. Unadjusted: Outcome of mixed model analysis, unadjusted for confounders. Adjusted: Outcome of mixed model analysis adjusted for maternal age, maternal BMI, maternal diabetes, parity and fetal gender.
*p < 0.05 is considered statistically significant.
Results of mixed model analysis in cortical area grading
| Average difference in grade over all times | Difference in maturation speed | ||||
|---|---|---|---|---|---|
| Difference | 95% CI |
|
| ||
| Frontal | Unadjusted | −0.01 | −0.12; 0.13 | 0.97 | 0.10 |
| Adjusted | −0.11 | −0.26; 0.04 | 0.14 | 0.38 | |
| Parietal | Unadjusted | −0.07 | −0.19; 0.05 | 0.24 | 0.01* |
| Adjusted | 0.10 | −0.25; 0.04 | 0.16 | 0.06 | |
| Temporal | Unadjusted | −0.09 | −0.22; −0.03 | 0.15 | 0.01* |
| Adjusted | −0.12 | −0.26; 0.03 | 0.11 | 0.09 | |
| Occipital | Unadjusted | −0.07 | −0.17; 0.03 | 0.23 | 0.08 |
| Adjusted | −0.08 | −0.20; 0.04 | 0.17 | 0.47 | |
Note: Overall difference in grading represent the difference between scores in CHD and control cases. Speed of maturation represents the test on differences in progression with GA between scores of CHD and control cases. Unadjusted: Outcome of mixed model analysis, unadjusted for confounders. Adjusted: Outcome of mixed model analysis, adjusted for maternal age, maternal BMI, maternal diabetes, parity, and fetal gender.
*p < 0.05 is considered statistically significant.